416 related articles for article (PubMed ID: 21813113)
1. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury.
Hama A; Sagen J
Exp Neurol; 2007 Mar; 204(1):454-7. PubMed ID: 17045264
[TBL] [Abstract][Full Text] [Related]
4. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
J Rehabil Res Dev; 2009; 46(1):135-43. PubMed ID: 19533526
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
[TBL] [Abstract][Full Text] [Related]
6. Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
Brownjohn PW; Ashton JC
Neuroscience; 2012 Feb; 203():180-93. PubMed ID: 22210507
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
Hama AT; Germano P; Varghese MS; Cravatt BF; Milne GT; Pearson JP; Sagen J
PLoS One; 2014; 9(5):e96396. PubMed ID: 24788435
[TBL] [Abstract][Full Text] [Related]
8. Topical cannabinoid antinociception: synergy with spinal sites.
Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain.
Hama A; Sagen J
J Neurotrauma; 2011 Jan; 28(1):127-34. PubMed ID: 20954888
[TBL] [Abstract][Full Text] [Related]
10. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
Liu C; Walker JM
J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
[TBL] [Abstract][Full Text] [Related]
12. Antihyperalgesic effect of the cannabinoid agonist WIN55,212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats.
Hama AT; Urban MO
Neurosci Lett; 2004 Mar; 358(1):21-4. PubMed ID: 15016425
[TBL] [Abstract][Full Text] [Related]
13. CB
Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
[TBL] [Abstract][Full Text] [Related]
14. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Liang YC; Huang CC; Hsu KS
Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
[TBL] [Abstract][Full Text] [Related]
15. Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain.
Zhu CZ; Mikusa JP; Fan Y; Hollingsworth PR; Pai M; Chandran P; Daza AV; Yao BB; Dart MJ; Meyer MD; Decker MW; Hsieh GC; Honore P
Br J Pharmacol; 2009 Jun; 157(4):645-55. PubMed ID: 19371344
[TBL] [Abstract][Full Text] [Related]
16. Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.
Dableh LJ; Yashpal K; Henry JL
Eur J Pharmacol; 2009 Jan; 602(1):36-40. PubMed ID: 19027734
[TBL] [Abstract][Full Text] [Related]
17. Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.
Hama A; Sagen J
Pharmacol Biochem Behav; 2011 Dec; 100(2):340-6. PubMed ID: 21958947
[TBL] [Abstract][Full Text] [Related]
18. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
Pascual D; Goicoechea C; Suardíaz M; Martín MI
Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
[TBL] [Abstract][Full Text] [Related]
19. Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.
Hama A; Sagen J
Eur J Pharmacol; 2012 May; 683(1-3):101-8. PubMed ID: 22449374
[TBL] [Abstract][Full Text] [Related]
20. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
